PEACHES PALMER: Open Payments
NPI 1235612706 · DIBERVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $263 |
| Dexcom, Inc. | 5 | $188 |
| REVANCE THERAPEUTICS, INC. | 1 | $142 |
| Amgen Inc. | 2 | $37 |
| PFIZER INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| GM Pharmaceuticals, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $16 |
Products named: DEXCOM G7 GSS (161), DAXXIFY, BREZTRI, AIRSUPRA, Dexcom G6 Transmitter, ELIQUIS, JARDIANCE, OTEZLA.
Industry payments across MS — which companies pay providers there.
